Sermorelin, by contrast, works on the GHRH pathway and at ThinWorks is offered as its own standalone therapy
These drugs mimic GLP-1, a gut hormone released after meals, to stimulate glucose?dependent insulin secretion, suppress glucagon, slow gastric emptying, reduce appetite, and improve glycaemic control and weight management
However, "greater average weight loss in clinical trials" doesn't automatically mean tirzepatide is better for every individual
It is not FDA-approved for general therapeutic use in humans, and the World Anti-Doping Agency added it to its Prohibited List in 2022
Instead of mimicking hormones like prescription injections, this supplement takes a different path supporting your bodys own systems for appetite, blood sugar, and energy balance